|
MechanismTRPV1 antagonists |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismNMDA receptor antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with DiverDrugs SL
0 Patents (Medical) associated with DiverDrugs SL
100 Deals associated with DiverDrugs SL
100 Translational Medicine associated with DiverDrugs SL